MedPath
NMPA Approval

Dexmedetomidine Hydrochloride Injection

国药准字H20243549

April 24, 2024

Drug Information

盐酸右美托咪定注射液

注射剂

2ml:200μg(按C₁₃H₁₆N₂计)

化学药品

April 24, 2024

Company Information

Applicant Company

南京经济技术开发区惠美路3号

Manufacturing Company

南京经济技术开发区惠美路3号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸右美托咪定注射液 - NMPA 批准文号 | MedPath